CLINICAL_TRIALS
trial_result
· 2026-08-26
Clinical Trial Results: Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris [Phase 2]
Summary
Phase 2 trial results of deucravacitinib (BMS-986165) for pityriasis rubra pilaris have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Pityriasis Rubra Pilaris | Phase 2 | Status: COMPLETED | Results posted: 2026-08-26